HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Resolution Urging Firms To Share Nanotech Policy Shows Investor Awareness

This article was originally published in The Rose Sheet

Executive Summary

A shareholder resolution set before Avon and Colgate-Palmolive by the Calvert Group reflects the investment community's growing awareness of nanotechnology and its potential liabilities

You may also be interested in...



New Super-Agency Needed For Consumer/Environment Protection – PEN Report

A new federal Department of Environmental and Consumer Protection is needed to oversee the technologies that will "shape the 21 century," ex-EPA official J. Clarence Davies writes in a report released April 28

New Super-Agency Needed For Consumer/Environment Protection – PEN Report

A new federal Department of Environmental and Consumer Protection is needed to oversee the technologies that will "shape the 21 century," ex-EPA official J. Clarence Davies writes in a report released April 28

Plan For President To Ensure Nanotech Safety Calls For Cosmetics Regulation

A new report from former Environmental Protection Agency official J. Clarence Davies - addressed to the next presidential administration - recommends a legislative fix to beef up FDA's oversight of cosmetics, one of two "major high-exposure applications of nanotechnology.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015426

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel